Dexrazoxane Intravenous and NovoLog PenFill
Determining the interaction of Dexrazoxane Intravenous and NovoLog PenFill and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Novoseven
- Dexrazoxane Intravenous-NovoSeven RT
- Dexrazoxane Intravenous-NovoSeven RT with MixPro injection
- Dexrazoxane Intravenous-Novothyrox
- Dexrazoxane Intravenous-Noxafil
- Dexrazoxane Intravenous-Noxafil (Posaconazole Delayed-Release Tablets)
- NovoLog PenFill-Dextenza Insert
- NovoLog PenFill-Dextenza intraocular
- NovoLog PenFill-Dextran 40
- NovoLog PenFill-Dextran 70 6% in 5% Dextrose high molecular weight
- NovoLog PenFill-Dextran 75
- NovoLog PenFill-Dextran high molecular weight